Dr. Kahanic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
230 Nebraska St
Sioux City, IA 51101Phone+1 712-252-0088Fax+1 712-252-5271
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1989 - 1992
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1986 - 1989
- Case Western Reserve University School of MedicineClass of 1986
Certifications & Licensure
- IA State Medical License 1989 - 2026
- NE State Medical License 1993 - 2018
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
Publications & Presentations
PubMed
- 91 citationsLonger term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) wit...Brian G.M. Durie, Antje Hoering, Rachael Sexton, Muneer H. Abidi, Joshua Epstein
Blood Cancer Journal. 2020-05-11 - 604 citationsBortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autolo...Brian G.M. Durie, Antje Hoering, Muneer H. Abidi, S. Vincent Rajkumar, Joshua Epstein
Lancet. 2017-02-04 - 28 citationsPilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)Bryan P. Schneider, Anne O'Neill, Fei Shen, George W. Sledge, Ann D. Thor
British Journal of Cancer. 2015-12-22
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: